World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
40489
World Ranking
7043
National Ranking
267

Overview

Socrates E. Papapoulos is affiliated with the Leiden University Medical Center in the Netherlands. Their research primarily focuses on medicine, with significant contributions to biochemistry, genetics, and molecular biology.

The scientist's work covers multiple subfields, including orthopedics and sports medicine, oncology, molecular biology, surgery, and genetics. Their main topics of study revolve around bone health and osteoporosis research, bone health and treatments, bone metabolism and diseases, hip and femur fractures, connective tissue disorders research, bone and joint diseases, and bone and dental protein studies.

Their publication record reflects contributions to several scientific journals. Key frequent publication venues include:

  • Osteoporosis International
  • Bone
  • Journal of Clinical Medicine
  • Bone Reports
  • The Journal of Clinical Endocrinology & Metabolism

Notable recent papers authored or co-authored by Socrates E. Papapoulos include:

  • "The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study" (2020), published in Osteoporosis International
  • "The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation" (2021), published in The Journal of Clinical Endocrinology & Metabolism
  • "The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis" (2020), published in Bone
  • "Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial" (2020), published in Journal of Bone and Mineral Research
  • "Pamidronate: A model compound of the pharmacology of nitrogen-containing bisphosphonates; A Leiden historical perspective" (2020), published in Bone

Socrates E. Papapoulos has collaborated frequently with several researchers in their field. Frequent co-authors include:

  • Natasha M. Appelman-Dijkstra
  • Polyzois Makras
  • Athanasios D. Anastasilakis
  • Stergios A. Polyzos
  • Elizabeth M. Winter

Their research topics demonstrate a strong emphasis on investigating bone-related diseases and therapeutic approaches, particularly involving osteoporosis and fracture incidence in postmenopausal women. The contributions have variously addressed clinical treatment gaps, efficacy of pharmacological agents such as denosumab and zoledronate, and bone mineral density outcomes over time.

Best Publications

  • Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

    Elizabeth Shane;David Burr;Peter R. Ebeling;Bo Abrahamsen

  • Primer on the metabolic bone diseases and disorders of mineral metabolism

    John P. Bilezikian;Roger Bouillon;Thomas Clemens;Juliet Compston

  • Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research Running Title: Atypical Femoral Fractures Task Force Report

    Elizabeth Shane;David Burr;Peter R. Ebeling;Bo

  • Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis

    H K Genant;C Cooper;G Poor;I Reid

  • Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

    Kenneth E. S. Poole;Rutger L. Van Bezooijen;Nigel Loveridge;Herman Hamersma

  • Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

    Rutger L. van Bezooijen;Bernard A.J. Roelen;Annemieke Visser;Lianne van der Wee-Pals

  • Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A

    Martine M. L. Deckers;Rutger L. van Bezooijen;Geertje van der Horst;Jakomijn Hoogendam

  • 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

    Henry G Bone;Rachel B Wagman;Maria L Brandi;Jacques P Brown

  • Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation.

    Martine M. L. Deckers;Marcel Karperien;Chris van der Bent;Takeyoshi Yamashita

  • Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing Bisphosphonates

    E. van Beek;E. Pieterman;L. Cohen;C. Löwik

  • Interpretation and use of FRAX in clinical practice

    J. A. Kanis;D. Hans;C. Cooper;C. Cooper;S. Baim

  • Pharmacology of bisphosphonates

    Serge Cremers;Socrates Papapoulos

  • A New Approach to the Development of Assessment Guidelines for Osteoporosis

    JA Kanis;D Black;C Cooper;P Dargent

  • Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis.

    C.W.G.M. Löwik;G. van der Pluijm;H. Bloys;K. Hoekman

  • Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension.

    Socrates Papapoulos;Roland Chapurlat;Cesar Libanati;Maria Luisa Brandi

  • Peroxisome Proliferator-activated Receptor γ (PPARγ) as a Molecular Target for the Soy Phytoestrogen Genistein

    Zhi-Chao Dang;Valérie Audinot;Socrates E. Papapoulos;Jean A. Boutin

  • Sclerostin: Current Knowledge and Future Perspectives

    M. J. C. Moester;S. E. Papapoulos;C. W. G. M. Löwik;R. L. van Bezooijen

  • Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies

    Andrea Giusti;Neveen A.T. Hamdy;Socrates E. Papapoulos

  • Wnt but Not BMP Signaling Is Involved in the Inhibitory Action of Sclerostin on BMP-Stimulated Bone Formation

    Rutger L. van Bezooijen;J. Peter Svensson;J. Peter Svensson;Daniël Eefting;Annemieke Visser

  • SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

    Rutger L. van Bezooijen;Peter ten Dijke;Socrates E. Papapoulos;Clemens W. G.M. Löwik

Frequent Co-Authors

Clemens W.G.M. Löwik
Clemens W.G.M. Löwik Erasmus University Rotterdam
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Marcel Karperien
Marcel Karperien University of Twente
Roland Chapurlat
Roland Chapurlat Claude Bernard University Lyon 1
Jacques P. Brown
Jacques P. Brown Université Laval
Cyrus Cooper
Cyrus Cooper University of Southampton
René Rizzoli
René Rizzoli Geneva College
Michael R. McClung
Michael R. McClung Australian Catholic University
Dan Mellström
Dan Mellström University of Gothenburg
Paul D. Miller
Paul D. Miller University of Colorado Anschutz Medical Campus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring ways to begin or advance your career in healthcare, there are a variety of flexible online pathways available. Many students choose to start their journey with a nursing degree. For those seeking affordability, the cheapest rn to bsn program online options can make higher education more accessible while also helping you qualify for higher-paying roles.

If you already hold a degree in another field but want to pivot into nursing, look for online msn programs for non nurses that provide a streamlined path to an advanced nursing credential.

For those concerned about acceptance rates, consider starting with easy nursing programs to get into. These schools offer more accessible admissions processes, helping more students kickstart their healthcare careers.

Not all healthcare roles require direct patient care. If you’re interested in healthcare administration, programs in online medical billing and coding with financial aid offer excellent entry points, often with flexible schedules and valuable job prospects.

Best Scientists Citing Socrates E. Papapoulos

Trending Scientists

Recently Published Articles